PITTSBURGH, March 15 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. announced today that the regular quarterly cash dividend of $.06 per share will be payable on April 16, 2007, to shareholders of record at the close of business on March 30, 2007.
Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products.
For more information about Mylan, visit www.mylan.com.
Mylan Laboratories, Inc.
CONTACT: Patrick Fitzgerald and Kris King, both of Mylan Laboratories,+1-724-514-1800
Web site: http://www.mylan.com/
